Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast c...
Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
About this item
Full title
Author / Creator
Publisher
Poland: De Gruyter Open
Journal title
Language
English
Formats
Publication information
Publisher
Poland: De Gruyter Open
Subjects
More information
Scope and Contents
Contents
Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients. The purpose of this study was to evaluate the correlation between traditional prognostic factors and uPA and...
Alternative Titles
Full title
Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0a111196451a4433865db452f0c6d85d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0a111196451a4433865db452f0c6d85d
Other Identifiers
ISSN
1318-2099,1581-3207
E-ISSN
1581-3207,0485-893X
DOI
10.2478/raon-2014-0049
